Artigo Acesso aberto Revisado por pares

Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications

2016; Project HOPE; Volume: 35; Issue: 12 Linguagem: Inglês

10.1377/hlthaff.2016.0623

ISSN

2694-233X

Autores

Colleen M. Grogan, Christina M. Andrews, Amanda J. Abraham, Keith Humphreys, Harold A. Pollack, Bikki Tran Smith, Peter D. Friedmann,

Tópico(s)

Primary Care and Health Outcomes

Resumo

The Affordable Care Act requires state Medicaid programs to cover substance use disorder treatment for their Medicaid expansion population but allows states to decide which individual services are reimbursable. To examine how states have defined substance use disorder benefit packages, we used data from 2013–14 that we collected as part of an ongoing nationwide survey of state Medicaid programs. Our findings highlight important state-level differences in coverage for substance use disorder treatment and opioid use disorder medications across the United States. Many states did not cover all levels of care required for effective substance use disorder treatment or medications required for effective opioid use disorder treatment as defined by American Society of Addiction Medicine criteria, which could result in lack of access to needed services for low-income populations.

Referência(s)